Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_provenance.
• NP156680.RAUis0hXF_GfiFMCpxD2_bideKMFLJRWu1pGsHmg-DpFY130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156680.RAUis0hXF_GfiFMCpxD2_bideKMFLJRWu1pGsHmg-DpFY130_provenance.
• NP775405.RABlIE0JE5SQKuSuXsmic0x-R1kbdxze9_3LWo5ptjTJA130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775405.RABlIE0JE5SQKuSuXsmic0x-R1kbdxze9_3LWo5ptjTJA130_provenance.
• assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP163529.RAEBb9gGxOtsNlbPWblgXZsxmhmp01Jzzu0nUqMq_Fr0k130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163529.RAEBb9gGxOtsNlbPWblgXZsxmhmp01Jzzu0nUqMq_Fr0k130_provenance.
• assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP646457.RAlFAivXHoG9l8ZwHkCs5ATteCGiy6-3pf49jkonLMU80130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646457.RAlFAivXHoG9l8ZwHkCs5ATteCGiy6-3pf49jkonLMU80130_provenance.
• NP646460.RAuWzQ_tLcrgFKqWsUulX9S_yNkOm4D4Ahpt16W37_tOI130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646460.RAuWzQ_tLcrgFKqWsUulX9S_yNkOm4D4Ahpt16W37_tOI130_provenance.
• NP646461.RAgFYvYOSDZo0aYtHRwWr125mKZbYwGxkNOvvWFCSPXyE130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646461.RAgFYvYOSDZo0aYtHRwWr125mKZbYwGxkNOvvWFCSPXyE130_provenance.
• NP646458.RAzpm_dUjt89n2PPMXC1lep8EBDpKzKfzM1XHD2H2_ReM130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646458.RAzpm_dUjt89n2PPMXC1lep8EBDpKzKfzM1XHD2H2_ReM130_provenance.